Enliven Therapeutics
ELVN
ELVN
35 hedge funds and large institutions have $33.6M invested in Enliven Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 8 closing their positions.
Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
9
Closed
8
Calls
–
Puts
$33K
Net Calls
-$33K
Net Calls Change
+$27K
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$1.9M |
| 2 |
PVI
2
Pura Vida Investments
New York
|
$440K |
| 3 |
3
Renaissance Technologies
New York
|
$989K |
| 4 |
WP
4
Woodline Partners
San Francisco,
California
|
$653K |
| 5 |
5
Morgan Stanley
New York
|
$744K |
